SEC announces charges against Praxsyn over claims relating to N95 masks in coronavirus pandemic

The Securities and Exchange Commission continued its crackdown on companies making false claims relating to tests or treatments for COVID-19 on Tuesday, by bringing charges against Praxsyn Corp. and its chief executive for false statement on N95 masks.